Effects of Smoking Addiction on Lower Limb Speed and Coordination
NCT ID: NCT07061522
Last Updated: 2025-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
24 participants
OBSERVATIONAL
2025-08-26
2026-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination
NCT07075068
Impact of Smoking on Physical Activity Level in Young Adults
NCT07043920
Exercise Training for Smoking Students
NCT06291558
Effects of Exercise and Nicotine on Cognition in Smokers
NCT03091699
Smoking and Health Among University Students
NCT06680570
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants aged 18-25 will be categorized into smoker and non-smoker groups based on DSM-IV-TR nicotine dependence criteria and the Fagerström Test. The Lower Extremity Motor Coordination Test (LEMOCOT) will be used to assess motor coordination, while a 30-meter sprint test will evaluate movement speed. Additionally, body mass index (BMI) and bimalleolar diameter and circumference will be recorded to control for confounding physical variables.
All assessments will be conducted in a controlled laboratory environment. The results will be analyzed to determine whether smoking addiction is associated with impaired lower limb motor function. The findings may provide new insights into the functional consequences of smoking in young adults and contribute to the design of preventive and rehabilitative strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smoking Addiction Group
Participants in this group will be individuals who meet the criteria for smoking addiction based on both the DSM-IV-TR criteria and the Fagerström Test for Nicotine Dependence. They must have smoked at least one cigarette per day for the past 12 months.
Behavioral/Physical Assessment
This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.
Non-Smokers
Participants in this group will be healthy individuals aged 18-25 with no history of smoking within the past year. They will be matched in terms of age and BMI to the smoking group and will serve as the control cohort.
Behavioral/Physical Assessment
This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral/Physical Assessment
This study will not include any therapeutic or clinical intervention. Instead, participants will undergo a series of structured physical and questionnaire-based assessments to evaluate lower extremity motor performance. These include the Fagerström Test for Nicotine Dependence and DSM-IV-TR criteria to classify smoking addiction. Anthropometric measurements such as Body Mass Index (BMI) and bimalleolar diameter/circumference will be recorded to assess potential confounding structural factors. Lower extremity coordination will be evaluated using the Lower Extremity Motor Coordination Test (LEMOCOT), and movement speed will be assessed with a 30-meter sprint test. All assessments will be conducted once in a controlled laboratory setting and are intended solely for comparative analysis between smokers and non-smokers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18-25
* Literate and cooperative
* BMI: 18.5-29.9 kg/m²
Exclusion Criteria
* Chronic pulmonary or cardiac disease
* Cognitive impairment
* BMI ≥30 kg/m²
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ESRA PEHLIVAN
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Esra Pehlivan
Istanbul, Üsküdar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Smoking Add-Coordination-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.